Year |
Citation |
Score |
2020 |
Rivera RR, Lin ME, Bornhop EC, Chun J. Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 34: 8833-8842. PMID 32929779 DOI: 10.1096/fj.202000317R |
0.562 |
|
2016 |
Wang D, Xue Y, Yan Y, Lin M, Yang J, Huang J, Hong Y. Reversal of neurochemical alterations in the spinal dorsal horn and dorsal root ganglia by Mas-related gene (Mrg) receptors in a rat model of spinal nerve injury. Neurobiology of Disease. PMID 27018398 DOI: 10.1016/j.nbd.2016.03.020 |
0.346 |
|
2013 |
Anliker B, Choi JW, Lin ME, Gardell SE, Rivera RR, Kennedy G, Chun J. Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation. Glia. 61: 2009-22. PMID 24115248 DOI: 10.1002/Glia.22572 |
0.652 |
|
2013 |
Mirendil H, Lin ME, Chun J. Lysophosphatidic Acid (LPA) Receptor Signaling Lysophospholipid Receptors: Signaling and Biochemistry. 1-39. DOI: 10.1002/9781118531426.ch1 |
0.682 |
|
2012 |
Lin ME, Rivera RR, Chun J. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. The Journal of Biological Chemistry. 287: 17608-17. PMID 22461625 DOI: 10.1074/Jbc.M111.330183 |
0.707 |
|
2011 |
Yung YC, Mutoh T, Lin ME, Noguchi K, Rivera RR, Choi JW, Kingsbury MA, Chun J. Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Science Translational Medicine. 3: 99ra87. PMID 21900594 DOI: 10.1126/Scitranslmed.3002095 |
0.729 |
|
2010 |
Lin ME, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins & Other Lipid Mediators. 91: 130-8. PMID 20331961 DOI: 10.1016/J.Prostaglandins.2009.02.002 |
0.815 |
|
2010 |
Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Annual Review of Pharmacology and Toxicology. 50: 157-86. PMID 20055701 DOI: 10.1146/Annurev.Pharmtox.010909.105753 |
0.467 |
|
2007 |
Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, Glass CK. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Molecular Cell. 25: 57-70. PMID 17218271 DOI: 10.1016/J.Molcel.2006.11.022 |
0.328 |
|
Show low-probability matches. |